Lantern Pharma (LTRN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

LTRN Lantern Pharma

Watchlist

3.310
+0.185+5.92%

Close Nov 1 16:00 ET

3.310
0.0000.00%

Post 20:02 ET

35.63MMarket Cap-2006P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Preview: LTRN to Report Financial Results Post-market on November 07
Moomoo NewsNov 1 08:45 ET
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2024
BusinesswireOct 23 08:45 ET
Lantern Pharma to Host & Participate in Two Public Webinars During October
Yahoo FinanceOct 21 08:00 ET
Express News | Lantern Pharma Inc - Phase 1B/2a Trial for Recurrent GBM to Start Late 2024
ReutersOct 15 09:07 ET
Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma From the FDA
BusinesswireOct 15 09:07 ET
Express News | Lantern Pharma’s Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma From the FDA
ReutersOct 15 09:07 ET

Comments

Trytosaveabit

Oct 15 08:14

News

$Lantern Pharma (LTRN.US)$ Lantern Pharma's Investigational Drug-Candidate, LP-184, Receives Fast-Track Designation in Glioblastoma from the FDA
6 MINUTES AGO, 9:07 AM EDT
VIA BUSINESSWIRE

Stock_Drift

Oct 11 16:26

After Hours Ticks. 5:23pm 10/11

$Hall Of Fame Resort & Entertainment (HOFV.US)$ $Vera Bradley (VRA.US)$ $Lantern Pharma (LTRN.US)$ $Passage Bio (PASG.US)$ $Sadot (SDOT.US)$ $EDC Publishing (EDUC.US)$ $SHL Telemedicine (SHLT.US)$ $Altamira Therapeutics (CYTO.US)$ $Indaptus Therapeutics (INDP.US)$ $QT Imaging (QTI.US)$ $MediaCo (MDIA.US)$ $Edesa Biotech (EDSA.US)$ $Expion360 (XPON.US)$ $Tevogen Bio Holdings (TVGN.US)$

Jaguar8

Sep 23 07:05

NEWS

$Lantern Pharma (LTRN.US)$
Lantern Pharma Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children's Cancers
• Lantern Pharma was granted the rare pediatric disease designation (RPDD) for drug-candidate, LP-184, in three cancer indications: Malignant Rhabdoid Tumors, Rhabdomyosarcoma, and Hepatoblastoma.
• This brings the total number of RPDDs for LP-184 to 4, including one previously granted for ATRT (Atypical Teratoid Rhabdoid Tumors)....

Trytosaveabit

Sep 1 14:28

Conflicted watching! Hehehe. Ifn I’m a Bear I dig the weekly. But ima Bull so I’m watching the daily!

$Lantern Pharma (LTRN.US)$ This possible play is purely chart driven! Thats the reason im sharing. So those that asked. Here is a example of some of what i look for. This is what brought my attention here🤔🤫

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

LTRN Lantern Pharma

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target